Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
17.56
-0.39 (-2.17%)
At close: Dec 5, 2025, 4:00 PM EST
17.22
-0.34 (-1.94%)
After-hours: Dec 5, 2025, 6:20 PM EST
Avalo Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 318 | 78 | 7 | 47 | 191 | 4,212 | |
| Market Cap Growth | 166.47% | 965.79% | -84.63% | -75.15% | -95.47% | -77.67% | |
| Enterprise Value | 207 | -1 | -1 | 52 | 153 | 4,180 | |
| Last Close Price | 17.56 | 7.43 | 9.10 | 1209.61 | 4895.96 | 7603.14 | |
| PS Ratio | 1658.50 | 176.29 | 3.79 | 2.63 | 35.37 | 628.78 | |
| PB Ratio | 3.42 | 0.58 | 1.00 | -4.35 | 8.27 | 171.49 | |
| P/TBV Ratio | 3.93 | 0.63 | - | - | 22.11 | 491.62 | |
| EV/Sales Ratio | 1080.05 | - | - | 2.87 | 28.36 | 624.03 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.26 | -1.98 | 1.53 | 0.06 | |
| Asset Turnover | 0.00 | 0.01 | 0.07 | 0.32 | 0.09 | 0.17 | |
| Inventory Turnover | - | - | - | 896.21 | 2444.83 | 2074.05 | |
| Quick Ratio | 14.00 | 19.42 | 1.64 | 0.68 | 2.99 | 1.53 | |
| Current Ratio | 14.28 | 19.95 | 1.82 | 0.74 | 3.11 | 1.71 | |
| Return on Equity (ROE) | -174.79% | -50.06% | - | -684.77% | -354.08% | -282.65% | |
| Return on Assets (ROA) | -37.18% | -29.75% | -53.91% | -32.95% | -82.82% | -74.02% | |
| Return on Capital (ROIC) | -71.36% | -35.69% | -146.88% | -54.11% | -121.58% | -122.42% | |
| Return on Capital Employed (ROCE) | -56.80% | -28.40% | -143.20% | -266.10% | -136.20% | -165.80% | |
| Earnings Yield | -31.31% | -45.18% | -432.43% | -87.80% | -44.19% | -1.51% | |
| FCF Yield | -16.41% | -63.10% | -422.75% | -56.58% | -37.19% | -0.96% | |
| Buyback Yield / Dilution | -450.90% | -2599.19% | -608.45% | -8.32% | -41.86% | -28.52% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.